Epigenetics of Post-exertional Malaise in Patients With ME/CFS
EPIME
The Influence of Epigenetic Modifications and Post-Exertional Malaise in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
1 other identifier
interventional
105
1 country
1
Brief Summary
Exploring epigenetic mechanisms of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) is crucial to understand the mechanisms underlying its pathophysiology. Three potential candidates have been selected (BDNF, COMT, and HDAC genes). DNA methylation in the promoter regions of those genes will be explored. The investigators designed a randomised controlled trial and will enrol 70 patients with ME/CFS and 35 age-, sex-, and BMI-matched healthy controls. Both groups will be randomised in 2 groups and receive either one session of aerobic exercise or a validated test designed to trigger mental stress and mental fatigue. The primary aim is to assess genetic and epigenetic mechanisms of BDNF, COMT and HDAC genes in response to exercise and the stress task.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2020
CompletedFirst Posted
Study publicly available on registry
May 7, 2020
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedNovember 7, 2023
November 1, 2023
2.1 years
April 27, 2020
November 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
DNA methylation
DNA methylation measured at several CpGs of the genes' promoter regions using pyrosequencing technology
Baseline through 1 week post intervention
Secondary Outcomes (4)
Clinical Symptoms
Baseline through 1 week post intervention
Pain sensitivity
Baseline through 1 week post intervention
Serum BDNF
Baseline through 1 week post intervention
Cortisol response
Baseline through 1 week post intervention
Other Outcomes (2)
General Health
Baseline
Gene's polymorphisms
Baseline
Study Arms (4)
ME/CFS Exercise
EXPERIMENTALPatients undergoing the physical stress test (aerobic power index)
Patients Stress
EXPERIMENTALPatients undergoing the mental stress task (MIST)
Healthy Exercise
ACTIVE COMPARATORHealthy controls undergoing the physical stress test (aerobic power index)
Healthy Stress
ACTIVE COMPARATORHealthy controls undergoing the mental stress task (MIST)
Interventions
Sub-maximal exercise test
Computerised mental arithmetic challenges and social evaluative threat tasks
Eligibility Criteria
You may qualify if:
- diagnosis of ME/CFS established by a MD experienced in the field of internal medicine and ME/CFS - according to the published international criteria developed by the Canadian Consensus Criteria (CCC);
- age between 18 and 70 years old;
- body mass index (BMI) below 30 (no obesity).
You may not qualify if:
- presence of other neurological disorders (Parkinson's disease, Multiple Sclerosis, etc);
- presence of systemic disorders (lupus erythematosus, rheumatoid arthritis, etc.);
- presence or history of cardiac disorders (coronary heart disease, history of heart failure, etc);
- presence or history of cancer;
- presence or history of neuropathic pain (e.g. pain related to herpes zoster virus);
- pregnancy;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Brussel
Brussels, 1090, Belgium
Related Publications (3)
de Vega WC, Vernon SD, McGowan PO. DNA methylation modifications associated with chronic fatigue syndrome. PLoS One. 2014 Aug 11;9(8):e104757. doi: 10.1371/journal.pone.0104757. eCollection 2014.
PMID: 25111603BACKGROUNDVangeel EB, Kempke S, Bakusic J, Godderis L, Luyten P, Van Heddegem L, Compernolle V, Persoons P, Lambrechts D, Izzi B, Freson K, Claes S. Glucocorticoid receptor DNA methylation and childhood trauma in chronic fatigue syndrome patients. J Psychosom Res. 2018 Jan;104:55-60. doi: 10.1016/j.jpsychores.2017.11.011. Epub 2017 Nov 20.
PMID: 29275786BACKGROUNDTrivedi MS, Oltra E, Sarria L, Rose N, Beljanski V, Fletcher MA, Klimas NG, Nathanson L. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns. PLoS One. 2018 Jul 23;13(7):e0201066. doi: 10.1371/journal.pone.0201066. eCollection 2018.
PMID: 30036399BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jo Nijs, PhD
Vrije Universiteit Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, principal investigator
Study Record Dates
First Submitted
April 27, 2020
First Posted
May 7, 2020
Study Start
April 1, 2021
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
November 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share